Correlation Between Neximmune and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neximmune and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neximmune and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neximmune and Neoleukin Therapeutics, you can compare the effects of market volatilities on Neximmune and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neximmune with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neximmune and Neoleukin Therapeutics.
Diversification Opportunities for Neximmune and Neoleukin Therapeutics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Neximmune and Neoleukin is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Neximmune and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Neximmune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neximmune are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Neximmune i.e., Neximmune and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Neximmune and Neoleukin Therapeutics
If you would invest 69.00 in Neoleukin Therapeutics on September 3, 2024 and sell it today you would earn a total of 0.00 from holding Neoleukin Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neximmune vs. Neoleukin Therapeutics
Performance |
Timeline |
Neximmune |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neximmune and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neximmune and Neoleukin Therapeutics
The main advantage of trading using opposite Neximmune and Neoleukin Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neximmune position performs unexpectedly, Neoleukin Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neoleukin Therapeutics will offset losses from the drop in Neoleukin Therapeutics' long position.Neximmune vs. ZyVersa Therapeutics | Neximmune vs. Palisade Bio | Neximmune vs. Unicycive Therapeutics | Neximmune vs. Immix Biopharma |
Neoleukin Therapeutics vs. CytomX Therapeutics | Neoleukin Therapeutics vs. Spero Therapeutics | Neoleukin Therapeutics vs. Instil Bio | Neoleukin Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Transaction History View history of all your transactions and understand their impact on performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |